It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
19h
Fin vs Fin on MSNZealthy vs Ro: Which Weight Loss Plan Works Best?Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...
THOMASVILLE, GA. — Flowers Foods Inc. stands “very well-prepared” amid a consumer migration away from traditional white and ...
Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...
The Alabama Poison Information Center has seen a major increase in calls relating to GLP-1 medications. Ozempic, Mounjaro, ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
A number of hospitals and health systems are reducing their workforces or jobs amid financial and operational challenges. Below are workforce reduction efforts or job eliminations announced in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results